Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

02.24.21

This Week’s EyewireTV

Featured Image
  • Introduction

  • AcuFocus Submits Premarket Approval Application to FDA for IC-8 Small Aperture IOL

    02:43

  • New World Medical Launches KDB GLIDE for Excisional Goniotomy

    0:53

  • Three OTC Eye Drops Launched for Relief of Ocular Allergy, Eye Itch, and Screen Time Irritation

    02:01

  • Conclusion

    0:10

LeftArrow-Grey Created with Sketch.

Latest COVID-19 Headlines

  • Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing

    Source: FirstWord

  • One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

    Source: USA Today

  • Pfizer, Moderna and J&J Tout Supercharged COVID-19 Vaccine Output, Eyeing Nearly 140 Million New Doses by March

    Source: FiercePharma

View BMC COVID-19 Breaking News

Latest News

02.25.21

Remembering Ophthalmic Industry Executive George Marcellino

Source: Iridex

02.25.21

Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing

Source: FirstWord

02.25.21

Allergan Submits New Drug Application for Investigational Eye Drop for the Treatment of Presbyopia

Source: Allergan

02.24.21

New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Beyond Acute Disease into Chronic Phase

Source: Horizon Therapeutics

  • upwards Created with Sketch.
    Stocks
  • calendar Created with Sketch.
    Events
  • grid Created with Sketch.
    Interests

02.24.21

One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

Source: USA Today

02.24.21

International Team Identifies 127 Glaucoma Genes in Largest Study of Its Kind

Source: Massachusetts Eye and Ear

02.24.21

NeurOptics Launches Virtual Pupillometry Education Platform

Source: NeurOptics

02.24.21

VRmagic Eyesi Slit Lamp Fundoscopy Module Launched in the UK

Source: Haag-Streit UK

STAY UPDATED

Created with Sketch. Created with Sketch. Created with Sketch.
Box Ad
Email-Grey Created with Sketch. SUBSCRIBE TO STAY UPDATED

STAY UPDATED

02.24.21

Pfizer, Moderna and J&J Tout Supercharged COVID-19 Vaccine Output, Eyeing Nearly 140 Million New Doses by March

Source: FiercePharma

02.23.21

FCI Ophthalmics Announces Availability of LacriJet for Monocanalicular Nasolacrimal Intubation

Source: FCI Ophthalmics

02.23.21

Lexitas Announces George N. Magrath, MD, MBA Assumes Role of Chief Executive Officer

Source: Lexitas

02.23.21

Topcon Announces US Launch of the Harmony Glaucoma Module

Source: Topcon

02.23.21

Bausch + Lomb Launches Alaway Preservative Free Antihistamine Eye Drops

Source: Bausch + Lomb

02.23.21

AcuFocus Submits US Premarket Approval Application to the FDA for Its IC-8 Small Aperture IOL

Source: AcuFocus

02.23.21

Optimo Medical and Ansys Partner Announce Partnership to Improve Surgery Preparation

Source: Optimo Medical

02.23.21

Allergan Launches Refresh Digital Lubricant Eye Drops

Source: Abbvie

View more stories

Stocks

Name Price Change
AbbVie $107.31 -1.27%
Adverum Biotechnologies $12.52 -5.79%
Aerie Pharmaceuticals, Inc. $15.81 -3.36%
Alcon $69.97 -0.1%
Aldeyra Therapeutics $11.70 -4.26%
Alimera Sciences, Inc. $7.95 -11.57%
Applied Genetic Technologies $5.29 -6.37%
Bausch Health Companies Inc. $31.28 +0.74%
Bayer $15.72 -6.4%
Biogen $277.26 -1.94%
Can-Fite Biopharma $2.16 -8.47%
Clearside Biomedical $3.25 -6.88%
Cooper Companies, Inc. $392.13 -0.11%
Eyegate Pharmaceuticals $6.06 -2.73%
Eyenovia, Inc. $6.03 -5.04%
EyePoint Pharmaceuticals $11.03 -2.3%
Glaukos $92.11 -4.48%
Harrow Health $7.68 -0.9%
Horizon Therapeutics $90.57 -5.14%
IRIDEX Corporation $6.00 -9.64%
Iveric Bio $6.01 -2.75%
Johnson & Johnson $162.70 +0.07%
Kala Pharmaceuticals $7.74 -13.38%
Merck & Company, Inc. $74.62 +0.07%
National Vision Holdings $47.66 -3.01%
NovaBay Pharmaceuticals, Inc. $1.12 -9.68%
Novartis AG Common Stock $86.71 -0.82%
Ocular Therapeutix $18.11 +1.4%
Omeros Corp. $19.24 -14.45%
Ophthotech Corporation $1.20 +6.19%
Osmotica $3.96 -4.35%
Oyster Point Pharma $20.02 -2.29%
Regeneron $453.19 -1.18%
Regenxbio $39.98 -2.44%
Roche $40.58 -2.36%
Second Sight Medical Products $1.85 -6.09%
STAAR Surgical Company $106.29 -7.46%
Takeda Pharmaceutical Company $16.75 -2.73%

STAY UPDATED

Created with Sketch. Created with Sketch. Created with Sketch.

EVENTS

VIEW MORE EVENTS

INTERESTS

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina

INSTAGRAM

@eyewirenews

Follow

eyewirenews

This week on EyewireTV 📺: New drug applications This week on EyewireTV 📺: New drug applications are submitted to the FDA for #dryeyedisease, ocular itching associated with allergic conjunctivitis, and mydriasis; and #Genentech announces results from two global phase 3 studies evaluating faricimab for diabetic macular edema. 

Link in bio to watch the episode. 👊 #eyecare #news #ophthalmology
Part 2 of our highly-anticipated year-in-review ep Part 2 of our highly-anticipated year-in-review episode is here! 👏👊 Link in bio to watch the leading ophthalmic news stories from the second half of 2020. #telehealth #telemedicine #genetherapy #eyewireTV
This week on EyewireTV 📱💻: #Ophthalmology wi This week on EyewireTV 📱💻: #Ophthalmology will experience cuts in Medicare payments after CMS releases its final physician fee schedule for 2021; a new BMC survey examines #COVID19 outbreaks within practices; and Topcon rolls out a new ocular telehealth software platform allowing for remote eye exams in real-time. 

Visit Eyewire.News to watch the episode. #eyecarenews
On this week’s episode of EyewireTV, ophthalmic On this week’s episode of EyewireTV, ophthalmic executives from #BauschandLomb, #Alcon, #JNJvision, and #ZEISS discuss navigating the #COVID19 pandemic. Link in bio to watch.

From the Eyewire News team, we’d like to wish everyone a happy and healthy Thanksgiving! #grateful #thankyou #ophthalmology
This week on EyewireTV 📺: Leica Microsystems re This week on EyewireTV 📺: Leica Microsystems releases a new intraoperative OCT solution; Norlase receives FDA clearance for a first-of-its-kind portable green laser photocoagulator; #BauschandLomb introduces a new delivery system for its Envista toric and monofocal IOLs; and topline data is released from a late-stage trial of Aurinia Pharmaceuticals’ dry eye drug candidate. Visit Eyewire.News to watch the episode. #eyecare #news
Word of mouth or social media? 🤔 Get insight in Word of mouth or social media? 🤔 Get insight into practice #marketing preferences and more during the pandemic with our market research survey results—visit CRSToday.com/survey to access. 

#ophthalmology #anteriorsegementsurgery #BMCvision #CRST
This week on EyewireTV 📺: A first-of-its-kind # This week on EyewireTV 📺: A first-of-its-kind #dryeye disease drug is approved by the FDA; @allerganeye announces topline phase 3 results for its investigational eye drop for presbyopia; and #Orasis Pharmaceuticals advances its own eye drop candidate for #presbyopia and initiates a phase 3 trial. Visit Eyewire.News to watch more. #ophthalmology #eyecare #news
The future of telehealth, marketing metrics, and m The future of telehealth, marketing metrics, and more during #COVID19. Read the results of the Anterior Segment Surgery survey issued by @cataract_refractive and BMC, now available at http://CRSToday.com/survey. 📲 

#ophthalmology #marketresearch #CRST
The results are in! 🎉 Get insights into the sta The results are in! 🎉 Get insights into the state of anterior segment surgery during the pandemic in the latest market research survey issued by #BMCVision and @cataract_refractive. See the results at: http://CRSToday.com/survey

#ophthalmology #CRST #COVID19
Load More... Follow on Instagram

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.